Pancreatic Cancer, Adult Clinical Trials

11 recruiting

Pancreatic Cancer, Adult Trials at a Glance

11 actively recruiting trials for pancreatic cancer, adult are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in London, Bologna, and Boston. Lead sponsors running pancreatic cancer, adult studies include City of Hope Medical Center, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud, and Beth Israel Deaconess Medical Center.

Browse pancreatic cancer, adult trials by phase

Treatments under study

About Pancreatic Cancer, Adult Clinical Trials

Looking for clinical trials for Pancreatic Cancer, Adult? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pancreatic Cancer, Adult trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pancreatic Cancer, Adult clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Pancreatic Cancer Screening for At-risk Individuals

Pancreatic Cancer, Adult
Beth Israel Deaconess Medical Center1,395 enrolled1 locationNCT05006131
Recruiting
Not Applicable

Prehab for Pancreatic Cancer Surgery

PrehabilitationPancreatic Cancer, Adult
University of Massachusetts, Worcester20 enrolled1 locationNCT07478185
Recruiting
Not Applicable

Surveillance of Pancreatic Health After Diabetes Diagnosis

Diabetes MellitusPancreatic Cancer, Adult
University Hospital Southampton NHS Foundation Trust15,000 enrolled31 locationsNCT06803771
Recruiting
Phase 2

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic NeoplasmsCancer of Pancreas+4 more
UNC Lineberger Comprehensive Cancer Center45 enrolled1 locationNCT03977233
Recruiting

The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling

Ovarian CancerBrest CancerProstate Cancers+2 more
Javier Toledo6,000 enrolled4 locationsNCT06717295
Recruiting

Pancreatic Cancer Detection Consortium

Pancreatic CancerPancreatic CarcinomaPancreatic Ductal Adenocarcinoma+10 more
City of Hope Medical Center2,000 enrolled11 locationsNCT06388967
Recruiting
Phase 2

Adebrelimab and Chidamide for Pancreatic Cancer

Pancreatic Cancer, Adult
Liu Xiufeng45 enrolled1 locationNCT06584227
Recruiting
Not Applicable

Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticoduodenectomy (CPD): A Mechanistic Study

Pancreatic Cancer, AdultCephalic Duodenopancreatectomy
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud20 enrolled1 locationNCT06852014
Recruiting

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

Gastric CancersEsophageal CancerCancer Screening+14 more
Second Affiliated Hospital, School of Medicine, Zhejiang University600 enrolled4 locationsNCT06822413
Recruiting
Not Applicable

Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer

Pancreatic Cancer, Adult
IRCCS Azienda Ospedaliero-Universitaria di Bologna30 enrolled1 locationNCT06800469
Recruiting

Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer

Pancreatic Cancer, AdultPerineural InvasionNeutrophil-to-Lymphocyte Ratio+1 more
University of Las Palmas de Gran Canaria323 enrolled1 locationNCT06747481